Exane Derivatives’s ProShares Short 7-10 Year Treasury TBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$53.9K Hold
2,000
0.03% 310
2022
Q1
$51.7K Hold
2,000
0.01% 563
2021
Q4
$48.6K Hold
2,000
0.01% 496
2021
Q3
$48.9K Hold
2,000
0.01% 615
2021
Q2
$48.9K Buy
+2,000
New +$49.7K 0.01% 652

Other funds holding TBX

Exane Derivatives's TBX Position: Q2 2022 in Review

Exane Derivatives held its ProShares Short 7-10 Year Treasury (TBX) position steady in Q2 2022 at 2,000 shares worth $53.9K. The position accounts for 0.03% of the portfolio, ranked #310.

Exane Derivatives first reported a position in TBX in Q2 2021 and has held it in 5 quarters since. 42 funds tracked by Wall St. Rank hold TBX as of Q2 2022.

  • Exane Derivatives held 2,000 shares of ProShares Short 7-10 Year Treasury worth $53.9K as of Q2 2022.
  • Exane Derivatives left its ProShares Short 7-10 Year Treasury share count unchanged in Q2 2022.
  • ProShares Short 7-10 Year Treasury made up 0.03% of Exane Derivatives's portfolio in Q2 2022, its #310 holding.
  • Exane Derivatives first reported a position in ProShares Short 7-10 Year Treasury in Q2 2021 and has held it in 5 quarters since.
  • 42 funds tracked by Wall St. Rank held ProShares Short 7-10 Year Treasury as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.